Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FITEC study in testicular cancer chemotherapy
NL-OMON31217Not yet recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bleomycin, etoposide and cisplatin in testicular cancer and Germ Cell Carcinoma, sponsored by Vrije University Medical Center. Primary endpoint: Free iron and iron-binding markers. Planned start Jun 2007; status: not yet recruiting.
02
Drugs
bleomycinetoposidecisplatin
03
Conditions
testicular cancerGerm Cell Carcinoma
Beyond the preview
Go deeper on NL-OMON31217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31217.